Skip to main content
. 2018 Dec 1;48(7):1023–1032. doi: 10.1007/s00256-018-3118-y

Fig. 2.

Fig. 2

a Effect of denosumab 60 mg once subcutaneously every 6 months on BMD (g/cm2; mean ± SD). b Effect of denosumab 60 mg once subcutaneously every 6 months on BSV (mean ± SD)